Skip to main content
Publication date
2016 05
Authors
Gregson, J Tang, M Ndembi, N Hamers, RL Rhee, SY Marconi, VC Diero, L Brooks, K Theys, K de Wit, TFR Arruda, M Garcia, F Monge, S Gunthard, HF Hoffmann, CJ Kanki, PJ Kumarasamy, N Kerschberger, B Mor, O Charpentier, C Todesco, E Rokx, C Gras, L Halvas, EK Sunpath, H Di Carlo, D Antinori, A Andreoni, M Latini, A Mussini, C Aghokeng, A Sonnerborg, A Neogi, U Fessel, WJ Agolory, S Yang, CF Blanco, JL Juma, JM Smit, E Schmidt, D Watera, C Asio, J Kirungi, W Tostevin, A El-Hay, T Clumeck, N Goedhals, D van Vuuren, C Bester, PA Sabin, C Mukui, I Santoro, MM Perno, CF Hunt, G Morris, L Camacho, R de Oliveira, T Pillay, D Schulter, E Murakami-Ogasawara, A Reyes-Teran, G Romero, K Avila-Rios, S Sirivichayakul, S Ruxrungtham, K Mekprasan, S Dunn, D Kaleebu, P Raizes, E Kantor, R Shafer, RW Gupta, RK
Group authors
TenoRes Study Grp
Author KI Usernames
Neogi, U|ujjneo Sonnerborg, A|andson
Pubmed ID
26831472
Journal
The Lancet. Infectious diseases
Doctype
Article
KI Connection
Låg
Mesh SV
Afrika söder om Sahara Anti-HIV-medel Antiretrovirusterapi, aggressiv Bensoxaziner Emtricitabin Global hälsa HIV-1 HIV-infektioner Lamivudin Människa Preexponeringsprofylax Resistens mot antivirala läkemedel Retrospektiva studier Reverstranskriptashämmare Tenofovirdisoproxil Virusbelastning
Mesh EN
Africa South of the Sahara Anti-HIV Agents Antiretroviral Therapy, Highly Active Benzoxazines Drug Resistance, Viral Emtricitabine Global Health HIV-1 HIV Infections Lamivudine Pre-Exposure Prophylaxis Retrospective Studies Reverse Transcriptase Inhibitors Tenofovir Viral Load
First date
2016-05-08T10:25:45.897Z